Nuvation Bio
Nuvation Bio is a biopharmaceutical company.
HQ location
New York City, United States
Website
Launch date
Employees
Market cap
$657m
loading funding rounds…
Aisling Capital(exited)
Altitude Life Science Ventures(exited)
EDBI(exited)
Omega Funds(exited)
Ally Bridge Group(exited)
Perceptive Advisors(exited)
BioBrit(exited)
EcoR1 Capital(exited)
Fidelity Investments(exited)
Citadel(exited)
Redmile Group(exited)
Boxer Capital(exited)
The Baupost Group(exited)
Arrize Capital(exited)
| USD | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | - | - | - | 95 % | 490 % | 54 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | - | - | - | (7189 %) | - | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | - | - | - | (7214 %) | (1469 %) | (216 %) | (135 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | - | - | - | 6658 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Nuvation Bio
Edit
ACQUISITION by Nuvation Bio Mar 2024